Skip to main content
. 2018 Apr 3;9(25):17430–17442. doi: 10.18632/oncotarget.24732

Table 3. Performance of single markers for discriminating CCA and PSC.

Biomarker(s) Cut-off Sensitivity % (95% CI) Specificity % (95% CI) AUC (95% CI)
CA19-9 (U/mL) > 37.0 74.2 (62.0–84.2) 74.2 (61.5–84.5) 0.789 (0.71–0.87)
LRG1 (μg/mL) > 57.5* 4.5 (0.9–12.1) 91.9 (82.2–97.3) 0.562 (0.461–0.662)
IL6 (pg/mL) > 48.4* 80.3 (68.7–89.1) 17.7 (9.2–29.5) 0.543 (0.443–0.643)
PKM2 (ng/mL) > 2.2 75.8 (63.6–85.5) 82.3 (70.5–90.8) 0.839 (0.768–0.91)
CYFRA21.1 (ng/mL) > 4.0 65.2 (52.4–76.5) 75.8 (63.3–85.8) 0.732 (0.645–0.819)
MUC5AC (ng/mL) > 0.67 60.6 (47.8–72.4) 82.3 (70.5–90.8) 0.72 (0.631–0.809)

CI = confidence interval.*Cut-offs used in previous study [21].